Submission Details
| 510(k) Number | K252589 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 15, 2025 |
| Decision Date | January 09, 2026 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K252589 is an FDA 510(k) clearance for the Corvair Monza, a Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (Class II — Special Controls, product code MHX), submitted by AliveCor, Inc. (Mountain View, US). The FDA issued a Cleared decision on January 9, 2026, 147 days after receiving the submission on August 15, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1025.
| 510(k) Number | K252589 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 15, 2025 |
| Decision Date | January 09, 2026 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MHX — Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1025 |